loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of COMPLERA reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    COMPLERA

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 396Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Atripla

    02 4Biktarvy

    03 1Complera /Eviplera

    04 6Complera/Eviplera

    05 8Descovy

    06 5Genvoya

    07 8Odefsey

    08 2Revenue share - Symtuza

    09 5Stribild

    10 3Symtuza

    11 9Truvada

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Complera/Eviplera

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Complera/Eviplera

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 269

    2019 Revenue in Millions : 406

    Growth (%) : -34

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Biktarvy

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Biktarvy

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 7,259

    2019 Revenue in Millions : 4,738

    Growth (%) : 53

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Descovy

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Descovy

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,861

    2019 Revenue in Millions : 1,500

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Stribild

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Stribild

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 196

    2019 Revenue in Millions : 369

    Growth (%) : -47

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Symtuza

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Symtuza

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 488

    2019 Revenue in Millions : 379

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Truvada

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Truvada

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,448

    2019 Revenue in Millions : 2,813

    Growth (%) : -49

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Genvoya

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Genvoya

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 3,338

    2019 Revenue in Millions : 3,931

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Atripla

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Atripla

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 349

    2019 Revenue in Millions : 600

    Growth (%) : -42

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Odefsey

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,672

    2019 Revenue in Millions : 1,655

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Truvada

    Emtricitabine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Truvada

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Gilead

    Emtricitabine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 371

    2020 Revenue in Millions : 1,448

    Growth (%) : -74

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF